5:26 PM
 | 
Apr 10, 2014
 |  BC Extra  |  Financial News

Adamas raises $48 million in IPO

Adamas Pharmaceuticals Inc. (NASDAQ:ADMS) raised $48 million through the sale of 3 million shares at $16 in an IPO underwritten by Credit Suisse; Piper Jaffray; William Blair; and Needham....

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >